Biclonal IGHV -4-34 Variant Hairy Cell Leukemia and CLL - Successful Treatment With Ibrutinib and Venetoclax

American Journal of Hematology - United States
doi 10.1002/ajh.25264
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Variant Form of Hairy Cell Leukemia

Clinical Case Reports
Medicine
2019English

Hairy Cell Leukemia-Variant Without Typical Morphology and With Near-Tetraploid DNA Content

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

A Unique Variant of Hairy Cell Leukemia in Japan.

Japanese Journal of Medicine
1990English

Higher Expression Levels of Activation-Induced Cytidine Deaminase Distinguish Hairy Cell Leukemia From Hairy Cell Leukemia-Variant and Splenic Marginal Zone Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Successful Treatment of Chronic Lymphocytic Leukemia Mutlifocal Central Nervous System Involvement With Ibrutinib

Turkish Journal of Haematology
Hematology
2018English

BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology
2013English

Advances in the Treatment of Hairy Cell Leukemia

Journal of Hematology & Thromboembolic Diseases
2015English

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL--Letter

Clinical Cancer Research
Cancer ResearchOncology
2016English

Venetoclax: Another Oral Therapy Option for Patients With CLL

Pharmacy Today
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy